// App-Quantinova.ai

: Trial in Progress: A Phase 4 Multicenter Study of Brentuximab Vedotin Treatment in Chinese Patients with CD30-Positive Cutaneous T-Cell Lymphoma

Researchers

Presenter

  • Qian Wang

Principal Investigators

  • Ming Jiang

  • Chunlei Zhang

  • Sheng Wu

  • Wenhan Jiang

  • Meng Ji

  • Tong Chen

Medical Centers

  • West China Hospital of Sichuan University, Sichuan, China

  • Huashan Hospital, Fudan University, Shanghai, China

  • Department of Hematology, Huashan Hospital, Fudan University, Shanghai, China

  • Peking University Third Hospital, Beijing, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Oncology (ONC)

Disease

  • Cutaneous T-cell lymphoma

  • Lymphomatoid papulosis

  • Non-Hodgkin's Lymphoma

  • Non‐Hodgkin Lymphoma

  • Hodgkin's Lymphoma

  • T-cell lymphoma

  • Lymphomas

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • brentuximab vedotin

  • Adcetris

  • Tigason

Outcome

  • N/A

Study Design

  • Efficacy

  • Safety

  • Open Label

  • Single Arm

  • Multicenteric

  • Global

Phase

  • IV

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved